Effectiveness of the Zenicog® Cognitive Rehabilitation Program for subacute Stroke Patients with Cognitive Impairment: A Randomized Controlled Trial/A pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008969

Enrollment

Registered

2023-11-23

Start date

2023-12-01

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : -Intervention Group: Participants in the intervention group will perform 24 sessions using the Zenicog® program installed on a tablet PC within 6 weeks. Sessions, each lasting 30 minutes, wil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with a first onset of stroke in the acute phase, occurring within 1 week to less than 6 months (including both hemorrhagic and ischemic strokes). 2) Selection criteria include a MMSE (Mini-Mental State Examination) score of = 26 points as the cutoff.

Exclusion criteria

Exclusion criteria: 1) Patients with limitations in using computerized devices due to auditory impairments are excluded. 2) Individuals with significant digital literacy difficulties, hindering smooth operation of smart devices, are also excluded. 3)Patients diagnosed with severe mental disorders such as schizophrenia, dissociative disorders, or depressive disorders (severe depressive disorders, secondary depressive disorders) are excluded. 4)Participants currently taking the following medications are excluded: Antipsychotic medications (antipsychotics, antidepressants, etc.) Anti-alcohol medications (medications for alcohol addiction treatment) Sedatives (tranquilizers, sedatives, benzodiazepine-based medications, etc.) Opioid medications (oxycodone, etc.)

Design outcomes

Primary

Measure	Time frame
Cognitive Function Indicator: Comprehensive Cognitive Indicator (K-MMSE2);Attention Concentration (Trail Making Test A);Working Memory (Digit Span, Visual Span Test;Executive Function (Trail Making Test B)	—

Secondary

Measure	Time frame
"Psychological Outcome Measures: Quality of Life Indicator (EQ-5D-5L), Self-Esteem (Self-Efficacy Scale), Depression (Korean Version of Center for Epidemiological Studies-Depression Scale, K-CES-D);Activities of Daily Living Indicator: Modified Barthel Index;Usability Analysis: Usability Test (Development Questionnaire)	—

Countries

Korea, Republic of

Contacts

Public Contacttaeksoo jeong

Catholic Kwandong University International St.Mary's Hospital

jeongtaeksoo8@gmail.com+82-32-290-3117

Outcome results